Compared to prior studies, the lack of prognostic significance of CDKN2A homozygous deletion by FISH in grade 2–3 IDH-mutant astrocytomas may reflect differences in cohort populations or technical differences between testing modalities. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).